Archive for the ‘bioengineering’ category: Page 158
Mar 6, 2018
New synthetic polymer kills antibiotic-resistant superbugs from the inside out
Posted by Klaus Baldauf in categories: bioengineering, biotech/medical, nanotechnology
A research team composed of scientists from the Institute of Bioengineering and Nanotechnology (IBN) of the Agency for Science, Technology and Research (A*STAR) and IBM Research has produced a new synthetic molecule that can target and kill five multidrug-resistant bacteria. This synthetic polymer was found to be non-toxic and could enable entirely new classes of therapeutics to address the growing problem of antibiotic-resistant superbugs.
The synthetic molecules are called guanidinium-functionalized polycarbonates and were found to be both biodegradable and non-toxic to human cells. Essentially, the positively-charged synthetic polymer enters a living body and binds specifically to certain bacteria cells by homing in on a microbial membrane’s related negative charge. Once attached to the bacteria, the polymer crosses the cell membrane and triggers the solidification of proteins and DNA in the cell, killing the bacteria.
Feb 28, 2018
This Lactose Intolerant Man Was Apparently Cured By A DIY Gene Therapy
Posted by Shane Hinshaw in categories: bioengineering, biotech/medical
Biohacking future of avoiding doctors?
This man claims experimental gene therapy cured his lactose intolerance.
Feb 27, 2018
Bioquark Inc. — Born2Invest — Ira Pastor
Posted by Ira S. Pastor in categories: aging, bioengineering, biotech/medical, business, disruptive technology, economics, employment, futurism, genetics, health
Tags: anti-aging, bioquark, biotech, health, healthspan, lifespan, longevity, regeneration, regenerative, wellness
Feb 27, 2018
All-star team of synthetic biologists raise $53 million for cancer therapy startup Senti
Posted by Klaus Baldauf in categories: bioengineering, biotech/medical, finance, genetics
A who’s-who from the world of synthetic biological research have come together to launch Senti Biosciences with $53 million in funding from a slew of venture capital investors.
Led by Tim Lu, a longtime researcher at the Massachusetts Institute of Technology and one of the founding fathers of synthetic biology, Senti’s aim is nothing less than developing therapies that are tailored to an individual’s unique biology — and their first target is cancer.
Here’s how Lu described a potential cancer treatment using Senti’s technology to me. “We take a cell derived from humans that we can insert our genetic circuits into… we insert the DNA and encoding and deliver those cells via an IV infusion. We have engineered the cells to locate where the tumors are… What we’ve been doing is engineering those cells to selectively trigger an immune response against the tumor.”
Feb 26, 2018
Bioquark Inc. — 20 Minutes of Influence Podcast — Ira Pastor
Posted by Ira S. Pastor in categories: aging, bioengineering, biotech/medical, business, disruptive technology, DNA, economics, finance, futurism, genetics
Tags: anti-aging, bioquark, biotech, health, healthspan, Life extension, lifespan, wellness
Feb 24, 2018
Bioquark Inc. — The Mind’s Eye Podcast — Ira Pastor
Posted by Ira S. Pastor in categories: aging, bioengineering, biological, biotech/medical, cryonics, DNA, futurism, genetics, health, life extension
Tags: anti-aging, bioquark, biotech, health, healthspan, immortality, lifespan, reanima, regeneration, wellness
Feb 23, 2018
Bioquark Inc. — Life After Death Technologies — Nation Swell
Posted by Ira S. Pastor in categories: aging, bioengineering, biotech/medical, cryonics, futurism, genetics, health, life extension, science, transhumanism
Feb 23, 2018
Bioquark Inc. — Good Men Project — Ira Pastor
Posted by Ira S. Pastor in categories: aging, bioengineering, biotech/medical, DNA, genetics, health, life extension, neuroscience, science, transhumanism
Tags: anti-aging, bioquark, biotech, health, healthspan, immortality, lifespan, longevity, reanima, regenerage, regeneration, wellness
Feb 22, 2018
Scientists Just Made Sheep-Human Hybrids. Here’s What You Need to Know
Posted by Shailesh Prasad in categories: bioengineering, biotech/medical
Researchers have achieved a new kind of chimeric first, producing sheep-human hybrid embryos that could one day represent the future of organ donation – by using body parts grown inside unnatural, engineered animals.
With that end goal in mind, scientists have created the first interspecies sheep-human chimera, introducing human stem cells into sheep embryos, resulting in a hybrid creature that’s more than 99 percent sheep – but also a tiny, little bit like you and me.
Admittedly, the human portion of the embryos created in the experiment – before they were destroyed after 28 days – is exceedingly small, but the fact it exists at all is what generates considerable controversy in this field of research.
Continue reading “Scientists Just Made Sheep-Human Hybrids. Here’s What You Need to Know” »